EUVIMEDEUVIMED entdecken
Open Access

Tubular PFKFB3 drives diabetic kidney fibrosis via lactate‑dependent H4K12 lactylation and HIPK2 transactivation

Mingkun Xu, Linhang Fu, Yulong Zhang, Xiuli Guo, Han Wu, Sijing Gao, Fei Xiao, Li Xu

International Journal of Molecular Medicine · 2026

DOI: 10.3892/ijmm.2026.5926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Mingkun Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, P.R. China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Phosphofructokinase-2, Protein Serine-Threonine Kinases, Histones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aerobic glycolysis is increasingly recognized as a pathogenic driver in diabetic kidney disease (DKD). However, the epigenetic role of its end product, lactate, remains largely undefined. Spatial transcriptomics analysis revealed active glycolysis in tubular epithelial cells. The participation of histone lactylation in DKD was confirmed through inhibition of histone lactylation by glycolysis inhibitors or lactate in vivo. The potential target genes of H4K12 lactylation (H4K12la) were screened by CUT&Tag analyses. The candidate target genes were validated through ChIP‑qPCR, RT‑qPCR and western blot analyses. The present study found that the expression of 6‑phosphofructo‑2‑kinase/fructose‑2,6‑biphosphatase 3 (PFKFB3), a pivotal glycolytic regulator, was markedly upregulated in tubular epithelial cells derived from patients with DKD and from the corresponding mouse models. Inhibition of the expression of PFKFB3 mitigated the kidney fibrotic process and alleviated renal function in a DKD mouse model. Conversely, upregulation of PFKFB3 expression aggravated renal fibrogenesis and promoted the deterioration of renal pathology. Moreover, it was demonstrated that the reduction in the levels of lactate levels markedly alleviated renal fibrosis in DKD. With regard to its mechanism of action, lactate was generated via PFKFB3‑driven glycolytic reprogramming and selectively enhanced H4K12 lactylation at the homeodomain‑interacting protein kinase 2 (HIPK2) promoter, thereby activating its transcription and driving renal fibrotic progression. These findings indicated that PFKFB3 in renal tubules upregulates HIPK2 expression via facilitating H4K12la‑dependent gene transcription. Therefore, intervention approaches targeting PFKFB3‑triggered HIPK2 activation in tubular cells may offer a novel therapeutic strategy for DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesPhosphofructokinase-2Protein Serine-Threonine KinasesHistonesKidney TubulesTranscriptional ActivationLactic AcidCarrier ProteinsAnimalsHumansFibrosisMiceMaleMice, Inbred C57BLEpithelial CellsCell Line

Stichwörter der Autor:innen

6‑biphosphatase 36‑phosphofructo‑2‑kinase/fructose‑2Histone H4Lysine 12 lactylationdiabetic kidney diseasetubular epithelial cells

Substanzen

Phosphofructokinase-2Protein Serine-Threonine KinasesHistonesPFKFB3 protein, mouseLactic AcidHipk2 protein, mouseHIPK2 protein, humanCarrier Proteins

Autor:innen und Institutionen

  • Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, P.R. China.
  • Department of Anesthesiology, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, P.R. China.
  • Department of Laboratory Medicine, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, P.R. China.
  • International Medical and Special Care Ward, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524002, P.R. China.
  • Department of Laboratory Medicine, Maoming People's Hospital, Maoming, Guangdong 525099, P.R. China.

Zitieren

APA

Xu, M., Fu, L., Zhang, Y., Guo, X., Wu, H., Gao, S., Xiao, F., & Xu, L. (2026). Tubular PFKFB3 drives diabetic kidney fibrosis via lactate‑dependent H4K12 lactylation and HIPK2 transactivation. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5926

Vancouver

Xu M, Fu L, Zhang Y, Guo X, Wu H, Gao S, et al. Tubular PFKFB3 drives diabetic kidney fibrosis via lactate‑dependent H4K12 lactylation and HIPK2 transactivation. International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5926

BibTeX
@article{Xu2026,
  author = {Xu, Mingkun and Fu, Linhang and Zhang, Yulong and Guo, Xiuli and Wu, Han and Gao, Sijing and Xiao, Fei and Xu, Li},
  title = {Tubular PFKFB3 drives diabetic kidney fibrosis via lactate‑dependent H4K12 lactylation and HIPK2 transactivation},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  doi = {10.3892/ijmm.2026.5926}
}
Kostenlos starten →